A 44-year-old male who developed liver failure four years after orthotopic liver transplant was managed using high-flux albumin haemofiltration as a bridge to transplant. The technique, which involves using conventional haemofiltration with a plasma component separator using a filter with a sieving coefficient of 20% for albumin, is described.
WelchCHarrisonDShortARowanK. The increasing burden of alcoholic liver disease on United Kingdom critical care units: secondary analysis of a high quality clinical database. J Health Serv Res Policy2008; 13: 40–44.
3.
MackleIJSwannDGCookB. One year outcome of intensive care patients with decompensated alcoholic liver disease. Br J Anaesth2006; 97: 496–98.
4.
The RENAL Replacement Therapy Study Investigators. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med2009; 361: 1627–38.
5.
SalernoFGerbesAGinesPHepatorenal syndrome in cirrhosis. Gut2007; 56: 1310–18.
6.
PalmesDQayumiKASpiegelH-U. Liver bridging techniques in the treatment of acute liver failure. J Investigat Surg2000; 13: 299–311.
7.
ZieveLShekeltonMLyftogtCDravesK. Ammonia, octanoate and a mercaptan depress regeneration of normal rat liver after partial hepatectomy. Hepatol2005, 5: 28–31.
8.
HesselFP. Economic evaluation of the artificial liver support system MARS in patients with acute-on-chronic liver failure. Cost Eff Resourc Alloc2006; 4: 16.
AzumaMNaitoHHashimotoSRemoval of low molecular weight protein from blood. Sh ch chiry (Intensive Crit Care Med)1995; 7: Supplement 111-2 (in Japanese).
11.
TaniguchiKMiyaharaT. EVACURETM* – Membrane plasma separator with Unique permeability properties. Med Sci Digest2002; 28: 247–51.
12.
NakaeHIgarashiTTajimiKCase report of hepatorenal syndrome treated with plasma diafiltration (Selective Plasma Filtration with Dialysis). Ther Apher Dial2007; 11: 391–95.
13.
HitomiYSatoNMoritaSPerformance stability of a membrane plasma separator “Evacure” in its continuous use. Jap J Apheresis2009; 28: 235–40.
14.
MatsubarkaeSOkabeNIyoakioKBlood purification of bilirubin acids by plasma exchange for liver failure and bile patients. Tohoku J Exp Med1986; 150: 83–90.
